Your browser doesn't support javascript.
loading
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.
Moore, Amy; Machiela, Mitchell J; Machado, Moara; Wang, Sophia S; Kane, Eleanor; Slager, Susan L; Zhou, Weiyin; Carrington, Mary; Lan, Qing; Milne, Roger L; Birmann, Brenda M; Adami, Hans-Olov; Albanes, Demetrius; Arslan, Alan A; Becker, Nikolaus; Benavente, Yolanda; Bisanzi, Simonetta; Boffetta, Paolo; Bracci, Paige M; Brennan, Paul; Brooks-Wilson, Angela R; Canzian, Federico; Caporaso, Neil; Clavel, Jacqueline; Cocco, Pierluigi; Conde, Lucia; Cox, David G; Cozen, Wendy; Curtin, Karen; De Vivo, Immaculata; de Sanjose, Silvia; Foretova, Lenka; Gapstur, Susan M; Ghesquières, Hervè; Giles, Graham G; Glenn, Martha; Glimelius, Bengt; Gao, Chi; Habermann, Thomas M; Hjalgrim, Henrik; Jackson, Rebecca D; Liebow, Mark; Link, Brian K; Maynadie, Marc; McKay, James; Melbye, Mads; Miligi, Lucia; Molina, Thierry J; Monnereau, Alain; Nieters, Alexandra.
Afiliação
  • Moore A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Machado M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Wang SS; Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
  • Kane E; Division of Health Analytics, City of Hope Beckman Research Institute, Duarte, CA 91010, USA.
  • Slager SL; Department of Health Sciences, University of York, York YO10 5DD, UK.
  • Zhou W; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Carrington M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Lan Q; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MD 20877, USA.
  • Milne RL; Basic Science Program, Frederick National Laboratory for Cancer Research in the Laboratory of Integrative Cancer Immunology, National Cancer Institute, Bethesda, MD 20892, USA.
  • Birmann BM; Ragon Institute of MGH, Cambridge, MA 02139, USA.
  • Adami HO; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Albanes D; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia.
  • Arslan AA; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia.
  • Becker N; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria 3800, Australia.
  • Benavente Y; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Bisanzi S; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17176, Sweden.
  • Boffetta P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Bracci PM; Institute of Health and Society, Clinical Effectiveness Research Group, University of Oslo, Oslo 0315, Norway.
  • Brennan P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Brooks-Wilson AR; Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.
  • Canzian F; Department of Population Health, New York University School of Medicine, New York, NY 10016, USA.
  • Caporaso N; Perlmutter Comprehensive Cancer Center, NYU Langone Health, New York, NY 10016, USA.
  • Clavel J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg 69120, Germany.
  • Cocco P; Cancer Epidemiology Research Programme, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona 08908, Spain.
  • Conde L; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Barcelona 08036, Spain.
  • Cox DG; Regional Cancer Prevention Laboratory, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence 50139, Italy.
  • Cozen W; Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA.
  • Curtin K; Department of Medical and Surgical Sciences, University of Bologna, Bologna 41026, Italy.
  • De Vivo I; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94118, USA.
  • de Sanjose S; International Agency for Research on Cancer (IARC), Lyon 69372, France.
  • Foretova L; Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia V5Z1L3, Canada.
  • Gapstur SM; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia V5A1S6, Canada.
  • Ghesquières H; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
  • Giles GG; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Glenn M; Center of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), UMR1153, INSERM, Villejuif 75004, France.
  • Glimelius B; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Cagliari 09042, Italy.
  • Gao C; Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
  • Habermann TM; INSERM U1052, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon 69008, France.
  • Hjalgrim H; Department of Preventive Medicine, USC Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Jackson RD; Norris Comprehensive Cancer Center, USC Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Liebow M; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
  • Link BK; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Maynadie M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • McKay J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Melbye M; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Barcelona 08036, Spain.
  • Miligi L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno 656 53, Czech Republic.
  • Molina TJ; Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA.
  • Monnereau A; Department of Hematology, Centre Léon Bérard, Lyon 69008, France.
  • Nieters A; INSERM U1052, Cancer Research Center of Lyon, Lyon-1 University, Pierre-Bénite Cedex 69008, France.
J Transl Genet Genom ; 5: 200-217, 2021.
Article em En | MEDLINE | ID: mdl-34622145
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Transl Genet Genom Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Transl Genet Genom Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos